logo.png
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024
August 13, 2024 07:00 ET | Centessa Pharmaceuticals plc
Company advancing pipeline of potential best-in-class orexin receptor 2 (OX2R) agonists Initiated Phase 1 clinical study with ORX750 being developed for sleep-wake disorders; Safety and efficacy data...
POAI New LOGO.jpg
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
August 13, 2024 07:00 ET | Predictive Oncology Inc.
Findings demonstrate real-world applications of Company’s AI platform to support biomarker discovery, clinical trial optimization and target validation Proprietary tool accounts for patient...
Isala Hospital The Netherlands
Philips and Dutch Isala Hospital renew long-term partnership focused on innovation and affordable, sustainable healthcare
August 13, 2024 04:00 ET | Royal Philips
August 13, 2024 Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Isala hospital (Zwolle, The Netherlands) have renewed their...
ogsk2sgeyptxenjnnf5a.png
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update
August 12, 2024 16:20 ET | Orchestra BioMed Holdings, Inc.
NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact...
logo-horizontal-main.png
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
August 12, 2024 16:10 ET | OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Biora-tm_rgb.jpg
Biora Therapeutics Announces Funding Agreement with Existing Investors
August 12, 2024 16:05 ET | Biora Therapeutics, Inc.
$16 million multiple-draw facility to be used as a bridge to anticipated pharma partnership
Empire Communities B
Empire Communities Becomes First Residential Builder in North America to Achieve ASHRAE 241’s Clean Air Requirements for Indoor Health with ERTH360 Air
August 12, 2024 14:24 ET | Empire Communities
Vaughan, Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Empire Communities, an award-winning residential homebuilder in Canada and the United States is proud to announce that its standard home model...
Logo.png
PROTAC Market is Expected to Showcase Significant Growth During the Study Period (2020–2034) | DelveInsight
August 12, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- PROTAC Market is Expected to Showcase Significant Growth During the Study Period (2020–2034) | DelveInsight  The PROTAC market is anticipated to...
Benevis Welcomes Dr.
Benevis Welcomes Dr. Eva Baciu to Benevis-affiliated Franklin Dental & Braces, Enhancing Dental Care Accessibility Across Families and Cultures
August 12, 2024 11:31 ET | Benevis
Atlanta, GA, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Benevis welcomes Dr. Eva Baciu, DDS, to the Franklin Dental & Braces team. She brings 11 years of dentistry experience and dedication to serving...
OnDemand Connect
Priority OnDemand Rebrands Digital Patient Logistics Division to OnDemand Connect
August 12, 2024 10:06 ET | Priority OnDemand
Knoxville, TN, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Priority OnDemand, a leading provider of healthcare solutions, announced today the rebranding of its digital patient logistics division, formerly...